Serial Biotech Entrepreneur, Cathy Tie, today announced the launch of Origin Genomics, a New York–based company dedicated to advancing precision germline gene correction for severe inherited diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results